首页>外文期刊>医学、药学、卫生>肿瘤学>Experimental Hematology Oncology

Experimental Hematology Oncology

中文名称：实验血液学肿瘤

ISSN：2162-3619
出版周期：-

发文量：275

期刊论文

热门论文

年度选择

2024
- 第1期
2023
- 第1期
2022
- 第1期
2021
- 第1期
2020
- 第1期
2019
- 第1期
2018
- 第1期
2017
- 第1期
2016
- 第1期
2015
- 第1期
2014
- 第1期
- 第8期
2013
- 第6期
- 第8期
2012
- 第6期

更多>>

全选（0）

1.JAK2V617F and p53 mutations coexist in erythroleukemia and megakaryoblastic leukemic cell lines

机译：JAK2V617F和p53突变共存于红白血病和巨核细胞白血病细胞系中
- 作者：Wanke Zhao;Yanhong Du;Wanting Tina Ho;Xueqi Fu;Zhizhuang Joe Zhao
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
2.Large granular lymphocytosis with severe neutropenia following ipilimumab therapy for metastatic melanoma

机译：伊匹木单抗治疗转移性黑色素瘤后出现大颗粒淋巴细胞增多伴严重中性粒细胞减少
- 作者：Guoqing Wei;Uzoma Nwakuche;Gustavo Cadavid;Asim Ajaz;Karen Seiter;Delong Liu
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
3.Immune modulation therapy in the management of bortezomib-induced peripheral neuropathy

机译：免疫调节疗法在硼替佐米引起的周围神经病变的治疗中
- 作者：Ashley Jeter;Yubin Kang
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
4.A Japanese case of chronic lymphocytic leukemia with t (1;6)

机译：一例日本慢性t淋巴细胞白血病（1; 6）
- 作者：Kayo Harada;Kazuhiko Ikeda;Hayato Matsumoto;Miki Furukawa;Hiroshi Takahashi;Hiroshi Ohkawara;Hideyoshi Noji;Kazuhiro Tasaki;Masafumi Abe;Kazuei Ogawa;Yasuchika Takeishi
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
5.Roles of Polo-like kinase 3 in suppressing tumor angiogenesis

机译：Polo样激酶3在抑制肿瘤血管生成中的作用
- 作者：Dazhong Xu;Qi Wang;Yongping Jiang;Yanxi Zhang;Eleazar Vega-SaenzdeMiera;Iman Osman;Wei Dai
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
6.Hyperphosphatemia during spontaneous tumor lysis syndrome culminate in severe hyphosphatemia at the time of blast crisis of Phneg CML to acute myelomoncytic leukemia

机译：自发性肿瘤溶解综合征中的高磷酸盐血症最终发生在Phneg CML爆炸性急性淋巴细胞白血病急性发作时严重的低磷酸盐血症。
- 作者：Ophira Salomon;Eli J Holtzman;Pazit Beckerman;Camila Avivi;Luba Trakhtenbrot;Abraham Kneller;Tali Tohami;Yeroham Kleinbaum;Sara Apter;Ninette Amariglio;Ehud Grossman;Ginette Schiby
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
7.Persistent complete molecular remission after nilotinib and graft-versus-leukemia effect in an acute lymphoblastic leukemia patient with cytogenetic relapse after allogeneic stem cell transplantation

机译：异基因干细胞移植后细胞遗传学复发的急性淋巴细胞白血病患者尼罗替尼和移植物抗白血病作用后的持久性完全分子缓解
- 作者：Paul Farnsworth;David Ward;Vijay Reddy
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
8.Numerical analysis of airflow alteration in central airways following tracheobronchial stent placement

机译：气管支气管支架置入后中央气道气流变化的数值分析
- 作者：Chien-Yi Ho;Hsiu-Mei Liao;Chih-Yen Tu;Chih-Yang Huang;Chuen-Ming Shih;Min-Ying Lydia Su;Jeon-Hor Chen;Tzu-Ching Shih
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
9.CD19: a biomarker for B cell development, lymphoma diagnosis and therapy

机译：CD19：B细胞发育，淋巴瘤诊断和治疗的生物标志物
- 作者：Kemeng Wang;Guoqing Wei;Delong Liu
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
10.Hypoglycemia associated with L-asparaginase in acute lymphoblastic leukemia treatment: a case report

机译：L-天冬酰胺酶相关的低血糖在急性淋巴细胞白血病中的治疗：一例报告
- 作者：Ryuma Tanaka;Tomoo Osumi;Masashi Miharu;Tomohiro Ishii;Tomonobu Hasegawa;Takao Takahashi;Hiroyuki Shimada
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
11.Long lasting complete molecular remission after suspending dasatinib treatment in chronic myeloid leukemia

机译：慢性粒细胞白血病中止达沙替尼治疗后持久的完全分子缓解
- 作者：Klára Gadó;András Matolcsy;Judit Csomor;Dóra Kicsi;Csaba B?d?r;Gyula Domján
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
12.Association of radiotherapy with preferential depletion of luminal epithelial cells in a BRCA1 mutation carrier

机译：放射疗法与BRCA1突变携带者中腔上皮细胞优先耗竭的关系
- 作者：Huai-Chin Chiang;Sreejith J Nair;I-Tien Yeh;Alfredo A Santillan;Yanfen Hu;Richard Elledge;Rong Li
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
13.Pediatric T-cell prolymphocytic leukemia with an isolated 12(p13) deletion and aberrant CD117 expression

机译：小儿T细胞淋巴细胞白血病，伴有孤立的12（p13）缺失和异常CD117表达
- 作者：Michael Bellone;Annika M Svensson;Ann-Leslie Zaslav;Silvia Spitzer;Marc Golightly;Mahmut Celiker;Youjun Hu;Yupo Ma;Tahmeena Ahmed
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
14.Treatment of splenic marginal zone lymphoma of the CNS with high-dose therapy and allogeneic stem cell transplantation

机译：大剂量联合异体干细胞移植治疗中枢神经系统脾边缘区淋巴瘤
- 作者：Christoph Busemann;Andrej Gudzuhn;Carsten Hirt;Michael Kirsch;Silke Vogelgesang;Christian A Schmidt;Gottfried D?lken;William H Krüger
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
15.Digitoxin and its analogs as novel cancer therapeutics

机译：Digitoxin及其类似物作为新型癌症治疗剂
- 作者：Hosam A Elbaz;Todd A Stueckle;William Tse;Yon Rojanasakul;Cerasela Zoica Dinu
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
16.R-CHOP with dose-attenuated radiation therapy could induce good prognosis in gastric diffuse large B cell lymphoma

机译：R-CHOP联合减毒放射治疗可诱导胃弥漫性大B细胞淋巴瘤预后良好
- 作者：Yuko Mishima;Yasuhito Terui;Masahiro Yokoyama;Noriko Nishimura;Sakura Sakajiri;Kyoko Ueda;Yasutoshi Kuboki;Kenji Nakano;Kazuhito Suzuki;Eriko Nara;Naoko Tsuyama;Kengo Takeuchi;Masahiko Oguchi;Kiyohiko Hatake
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
17.Thalidomide and its analogues in the treatment of Multiple Myeloma

机译：沙利度胺及其类似物在多发性骨髓瘤的治疗中
- 作者：Tahir Latif;Nabeel Chauhan;Rashid Khan;Andrea Moran;Saad Z Usmani
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
18.Polo-like kinase 1 as target for cancer therapy

机译：马球样激酶1作为癌症治疗的靶标
- 作者：Lily Wei?;Thomas Efferth
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
19.Current management and prognostic features for gastrointestinal stromal tumor (GIST)

机译：胃肠道间质瘤（GIST）的当前管理和预后特征
- 作者：Gurpreet Lamba;Ridhi Gupta;Byung Lee;Samir Ambrale;Delong Liu
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
20.Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis

机译：脂质体阿霉素与常规蒽环类抗生素的安全性和毒性比较：一项荟萃分析
- 作者：Shamudheen M Rafiyath;Mohammad Rasul;Byung Lee;Guoqing Wei;Gurpreet Lamba;Delong Liu
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
21.Impact of tandem autologous stem cell transplantation and response to transplant in the outcome of multiple myeloma

机译：串联自体干细胞移植及其对移植的反应对多发性骨髓瘤的影响
- 作者：Rui Bergantim;Fernanda Trigo;José E Guimar?es
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
22.Outcome of match related allogeneic stem cell transplantation procedures performed from 2004 till 2011

机译：2004年至2011年进行的与比赛相关的同种异体干细胞移植手术的结果
- 作者：Natasha Ali;Salman Naseem Adil;Mohammad Usman Shaikh;Munira Moosajee;Nehal Masood
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
23.Cytokine-induced killer (CIK) cell therapy for patients with hepatocellular carcinoma: efficacy and safety

机译：细胞因子诱导的杀伤（CIK）细胞疗法对肝细胞癌的疗效和安全性
- 作者：Yue Ma;Ying-Chun Xu;Lei Tang;Zan Zhang;Jian Wang;Hong-Xia Wang
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
24.BIRC6 (APOLLON) is down-regulated in acute myeloid leukemia and its knockdown attenuates neutrophil differentiation

机译：BIRC6（APOLLON）在急性髓细胞白血病中被下调，其敲低会减弱中性粒细胞的分化
- 作者：Anna M Schl?fli;Bruce E Torbett;Martin F Fey;Mario P Tschan
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
25.“T-cell prolymphocytic leukemia (T-PLL), a heterogeneous disease exemplified by two cases and the important role of cytogenetics: a multidisciplinary approach”

机译：“ T细胞淋巴细胞白血病（T-PLL），一种异质性疾病，以两个病例为例，并且细胞遗传学的重要作用：多学科方法”
- 作者：Carlos A Tirado;Phillip Starshak;Paul Delgado;Nagesh Rao
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
26.Expansion of hematopoietic stem cells for transplantation: current perspectives

机译：扩增造血干细胞用于移植：当前观点
- 作者：Jessica A Schuster;Maria R Stupnikov;Gina Ma;Wenbin Liao;Raymond Lai;Yupo Ma;Jerell R Aguila
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
27.Isolated cardiac metastasis from plasmacytoid urothelial carcinoma of the bladder

机译：膀胱浆细胞样尿路上皮癌的单纯心脏转移
- 作者：Joshua R Peck;Charles L Hitchcock;Sara Maguire;Jennifer Dickerson;Charles Bush
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
28.Quantification of minimal residual disease (MRD) in acute lymphoblastic leukemia (ALL) using amplicon-fusion-site polymerase chain reaction (AFS-PCR)

机译：使用扩增子融合位点聚合酶链反应（AFS-PCR）定量急性淋巴细胞白血病（ALL）中的最小残留疾病（MRD）
- 作者：Axel Weber;Sylvia Taube;Udo zur Stadt;Martin Horstmann;Knut Krohn;Jutta Bradtke;Andrea Teigler-Schlegel;Sabine Leiblein;Holger Christiansen
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
29.Clinical significance of E2F1 protein expression in non-small cell lung cancer

机译：E2F1蛋白在非小细胞肺癌中表达的临床意义
- 作者：Jung-Jyh Hung;Chung-Tsen Hsueh;Kuan-Hua Chen;Wen-Hu Hsu;Yu-Chung Wu
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
30.Ratio of involved/uninvolved immunoglobulin quantification by Hevylite? assay: clinical and prognostic impact in multiple myeloma

机译：Hevylite定量参与/未参与免疫球蛋白的比例？分析：多发性骨髓瘤的临床和预后影响
- 作者：Efstathios Koulieris;Panayiotis Panayiotidis;Stephen J Harding;Nikolitsa Kafasi;Dimitris Maltezas;Vassiliki Bartzis;Tatiana Tzenou;Maria Dimou;George Georgiou;Ladan Mirbahai;Arthur R Bradwell;Marie-Christine Kyrtsonis
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
31.Molecular monitoring of minimal residual disease in two patients with MLL-rearranged acute myeloid leukemia and haploidentical transplantation after relapse

机译：两名MLL重排的急性髓细胞白血病和复发后单倍体移植患者的最小残留疾病的分子监测
- 作者：Thomas Burmeister;Mara Molkentin;Claus Meyer;Nils Lachmann;Stefan Schwartz;Birte Friedrichs;J?rg Beyer;Igor Wolfgang Blau;Gunnar Lohm;Carola Tietze-Bürger;Rolf Marschalek;Lutz Uharek
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
32.Pattern of antigen expression in metastases after radioimmunotherapy of a syngeneic rat colon carcinoma utilizing the BR96 antibody

机译：使用BR96抗体对同种大鼠结肠癌进行放射免疫治疗后转移灶中抗原表达的模式
- 作者：Erika Elgstr?m;Sophie E Eriksson;Tomas G Ohlsson;Jan Tennvall;Rune Nilsson
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
33.Oxidative stress and redox state-regulating enzymes have prognostic relevance in diffuse large B-cell lymphoma

机译：氧化应激和氧化还原状态调节酶与弥漫性大B细胞淋巴瘤的预后相关
- 作者：Pekka Peroja;Anna Kaisa Pasanen;Kirsi-Maria Haapasaari;Esa Jantunen;Ylermi Soini;Taina Turpeenniemi-Hujanen;Risto Bloigu;Laura Lilja;Outi Kuittinen;Peeter Karihtala
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
34.Eculizumab in paroxysmal nocturnal hemoglobinuria with Budd-Chiari syndrome progressing despite anticoagulation

机译：尽管有抗凝治疗，依库丽单抗治疗阵发性夜间血红蛋白尿伴Budd-Chiari综合征的进展
- 作者：Andrés Brodsky;Octavio Mazzocchi;Fabiana Sánchez;Gus Khursigara;Suneil Malhotra;Mariano Volpacchio
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
35.The role of BCL11B in hematological malignancy

机译：BCL11B在血液系统恶性肿瘤中的作用
- 作者：Xin Huang;Xin Du;Yangqiu Li
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
36.French “real life” experience of clofarabine in children with refractory or relapsed acute lymphoblastic leukaemia

机译：法国对难治性或复发性急性淋巴细胞白血病患儿使用氯法拉滨的“现实生活”经历
- 作者：Pascale Trioche;Brigitte Nelken;Gérard Michel;Isabelle Pellier;Arnaud Petit;Yves Bertrand;Pierre Rohrlich;Claudine Schmitt;Nicolas Sirvent;Patrick Boutard;Geneviève Margueritte;Brigitte Pautard;Stéphane Ducassou;Dominique Plantaz;Alain Robert;Caroline Thomas;Kristell Desseaux;Sylvie Chevret;André Baruchel
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
37.Publish, not perish: Introducing Experimental Hematology & Oncology

机译：发表，而不是灭亡：实验血液学与肿瘤学简介
- 作者：Zihai Li;Chung-Tsen Hsueh;Delong Liu
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
38.Response of hemorrhagic bullous skin lesions of the breast secondary to primary systemic amyloidosis to a five-drug combination chemotherapy: a case report and review of the literature

机译：继发于原发性系统性淀粉样变性的乳腺出血性大疱性皮肤病变对五药联合化疗的反应：一例并文献复习
- 作者：Aref Agheli;Marvin Becker;Gary Becker;M Rashid Chaudhry;Jen C Wang
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
39.Intravascular CNS lymphoma: Successful therapy using high-dose methotrexate-based polychemotherapy

机译：血管内中枢神经系统淋巴瘤：使用基于甲氨蝶呤的大剂量多化学疗法成功治疗
- 作者：Sied Kebir;Klaus Kuchelmeister;Pitt Niehusmann;Michael Nelles;Young Kim;Sharmilan Thanendrarajan;Niklas Sch?fer;Moritz Stuplich;Frederic Mack;Bj?rn Scheffler;Horst Urbach;Martin Glas;Ulrich Herrlinger
- 期刊名称：《Experimental Hematology Oncology》 | 2012年第6期
40.Autoantibodies to tumor-associated antigens as biomarkers in human hepatocellular carcinoma (HCC)

机译：肿瘤相关抗原的自身抗体作为人类肝细胞癌（HCC）的生物标志物
- 作者：Liping Dai;Ningjing Lei;Mei Liu;Jian-Ying Zhang
- 期刊名称：《Experimental Hematology Oncology》 | 2013年第6期
41.Genetic profiles of plasmacytoid (BDCA-4 expressing) DC subtypes-clues to DC subtype function in vivo

机译：浆细胞样（表达BDCA-4的）DC亚型的遗传概况-体内DC亚型功能的线索
- 作者：Stephen H Wrzesinski;Jan L Fisher;Marc S Ernstoff
- 期刊名称：《Experimental Hematology Oncology》 | 2013年第6期
42.Opticin, a small leucine-rich proteoglycan, is uniquely expressed and translocated to the nucleus of chronic lymphocytic leukemia cells

机译：Opticin是一种富含亮氨酸的小蛋白聚糖，独特表达并易位至慢性淋巴细胞性白血病细胞核
- 作者：Eva Mikaelsson;Anders ?sterborg;Zahra Tahmasebi Fard;Ahmad Mahmoudi;Jafar Mahmoudian;Mahmood Jeddi-Tehrani;Mehdi Akhondi;Fazel Shokri;Paul N Bishop;Hodjattallah Rabbani;H?kan Mellstedt
- 期刊名称：《Experimental Hematology Oncology》 | 2013年第6期
43.Neoadjuvant treatment of melanoma: case reports and review

机译：黑色素瘤的新辅助治疗：病例报告和审查
- 作者：Shachar Laks;Kevin A Brueske;Eddy C Hsueh
- 期刊名称：《Experimental Hematology Oncology》 | 2013年第6期
44.Cancer immunotherapy: are we there yet?

机译：癌症免疫疗法：我们到了吗？
- 作者：Zihai Li;Lieping Chen;Mark P Rubinstein
- 期刊名称：《Experimental Hematology Oncology》 | 2013年第6期
45.Increased expression of miR-221 is associated with shorter overall survival in T-cell acute lymphoid leukemia

机译：miR-221表达的增加与T细胞急性淋巴白血病的总体生存期缩短有关
- 作者：Hamilton L Gimenes-Teixeira;Antonio R Lucena-Araujo;Guilherme A dos Santos;Dalila L Zanette;Priscila S Scheucher;Luciana C Oliveira;Leandro F Dalmazzo;Wilson A Silva-Júnior;Roberto P Falc?o;Eduardo M Rego
- 期刊名称：《Experimental Hematology Oncology》 | 2013年第6期
46.Optimization of cytarabine (ARA-C) therapy for acute myeloid leukemia

机译：阿糖胞苷（ARA-C）治疗急性髓性白血病的优化
- 作者：Richard L Momparler
- 期刊名称：《Experimental Hematology Oncology》 | 2013年第6期
47.Vincristine could partly suppress stromal support to T-ALL blasts during pegylated arginase I treatment

机译：长春新碱可部分抑制聚乙二醇精氨酸酶I治疗期间对T-ALL胚芽的基质支持
- 作者：Fung Kwong-Lam;Chan Godfrey Chi-Fung
- 期刊名称：《Experimental Hematology Oncology》 | 2013年第6期
48.Inhibition of transketolase by oxythiamine altered dynamics of protein signals in pancreatic cancer cells

机译：羟乙胺对转酮醇酶的抑制改变了胰腺癌细胞中蛋白质信号的动力学
- 作者：Jiarui Wang;Xuemei Zhang;Danjun Ma;Wai-Nang Paul Lee;Jing Xiao;Yingchun Zhao;Vay Liang Go;Qi Wang;Yun Yen;Robert Recker;Gary Guishan Xiao
- 期刊名称：《Experimental Hematology Oncology》 | 2013年第6期
49.The combined expression of the stromal markers fibronectin and SPARC improves the prediction of survival in diffuse large B-cell lymphoma

机译：基质标志物纤连蛋白和SPARC的联合表达改善了弥漫性大B细胞淋巴瘤生存的预测
- 作者：Simone Brandt;Chiara Montagna;Antoin Georgis;Peter J Schüffler;Marco M Bühler;Burkhardt Seifert;Thore Thiesler;Alessandra Curioni-Fontecedro;Ivan Hegyi;Silvia Dehler;Vittoria Martin;Marianne Tinguely;Davide Soldini
- 期刊名称：《Experimental Hematology Oncology》 | 2013年第6期
50.Bone marrow non-mesenchymal mononuclear cells induce functional differentiation of neuroblastoma cells

机译：骨髓非间充质单个核细胞诱导神经母细胞瘤细胞功能分化
- 作者：Chareerut Phruksaniyom;Permphan Dharmasaroja;Surapol Issaragrisil
- 期刊名称：《Experimental Hematology Oncology》 | 2013年第6期
51.Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant

机译：T细胞耗尽移植后第二次同种异体干细胞移植后疾病复发的结果与第一次移植后的缓解状态和缓解持续时间相关
- 作者：Yun Fan;Andrew S. Artz;Koen van Besien;Wendy Stock;Richard A. Larson;Olatoyosi Odenike;Lucy A. Godley;Justin Kline;John M. Cunningham;James L. LaBelle;Michael R. Bishop;Hongtao Liu
- 期刊名称：《Experimental Hematology Oncology》 | 2019年第1期
- Second allogeneic bone marrow transplantationT cell depletionNon-relapse mortality;
52.The Karolinska experience of autologous stem-cell transplantation for lymphoma: a population-based study of all 433 patients 1994–2016

机译：淋巴瘤自体干细胞移植的Karolinska经验：1994 - 2016年所有433例患者的基于人群的研究
- 作者：Mattias Carlsten;Martin J?dersten;Anna Hellstr?m;Karin Littmann;Christopher M. Melén;Henna Riikka Junlén;Kristina Sonnevi;Per Ljungman;Bo Bj?rkstrand;Bj?rn Engelbrekt Wahlin
- 期刊名称：《Experimental Hematology Oncology》 | 2019年第1期
- Autologous stem cell transplantationASCTBEAMLymphomaReal-worldSurvival;
53.Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored dose

机译：杜鹃花毒素靶向难治性MDS，但在量身定制的剂量下施用健康的血小杂物
- 作者：Stefanie Jilg;Richard T. Hauch;Johanna Kauschinger;Lars Buschhorn;Timo O. Odinius;Veronika Dill;Catharina Müller-Thomas;Tobias Herold;Peter M. Prodinger;Burkhard Schmidt;Dirk Hempel;Florian Bassermann;Christian Peschel;Katharina S. G?tze;Ulrike H?ckendorf;Torsten Haferlach;Philipp J. Jost
- 期刊名称：《Experimental Hematology Oncology》 | 2019年第1期
- MDSVenetoclaxCombination therapyHematotoxicityHMA failure;
54.NRAS and KRAS polymorphisms are not associated with hepatoblastoma susceptibility in Chinese children

机译：NRAS和KRA多态性与中国儿童的肝细胞瘤易感性无关
- 作者：Tianyou Yang;Yang Wen;Jiahao Li;Tianbao Tan;Jiliang Yang;Jing Pan;Chao Hu;Yuxiao Yao;Jiao Zhang;Yijuan Xin;Suhong Li;Huimin Xia;Jing He;Yan Zou
- 期刊名称：《Experimental Hematology Oncology》 | 2019年第1期
- HepatoblastomaCancer susceptibilityNRASKRASPolymorphism;
55.Development of a high resolution melting analysis assay for rapid identification of JAK2 V617F missense mutation and its validation

机译：高分辨率熔化分析测定的开发，用于快速鉴定JAK2 V617F致密突变及其验证
- 作者：Alireza Moradabadi;Alireza Farsinejad;Behzad Khansarinejad;Ahamd Fatemi
- 期刊名称：《Experimental Hematology Oncology》 | 2019年第1期
- JAK2 V617FARMS PCRPCR RFLPHRMDiagnosis methods;
56.Novel GTF2I–PDGFRB and IKZF1–TYW1 fusions in pediatric leukemia with normal karyotype

机译：小型GTF2I-PDGFRB和IKZF1-TYW1具有正常核型儿科白血病的融合
- 作者：Ioannis Panagopoulos;Marta Brunetti;Margrethe Stoltenberg;R?nnaug A. U. Strandab?;Julie Staurseth;Kristin Andersen;Ilyá Kostolomov;Tarjei S. Hveem;Susanne Lorenz;Tove Anita Nystad;Trond Fl?gstad;Francesca Micci;Sverre Heim
- 期刊名称：《Experimental Hematology Oncology》 | 2019年第1期
- Pediatric acute lymphoblastic leukemiaNormal karyotypeSubmicroscopic deletionsFusion genesGTF2I–PDGFRBFluorescence in situ hybridizationArray comparative genomic hybridizationRNA sequencingGTF2I–PDGFRBIKZF1–TYW1;
57.An expanded biomarker panel for the detection of prostate cancer from urine DNA

机译：一种膨胀生物标志物，用于检测来自尿液DNA前列腺癌
- 作者：Igor Brikun;Deborah Nusskern;Diha Freije
- 期刊名称：《Experimental Hematology Oncology》 | 2019年第1期
- Prostate cancerPSALiquid biopsyCirculating DNABiomarkersDNA methylation;
58.Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma

机译：Nivolumab与Ipilimumab与Nivolumab单药治疗和Ipilemimab单药治疗晚期黑色素瘤的医疗成本比较分析
- 作者：Ravi Potluri;Sandip Ranjan;Hitesh Bhandari;Helen Johnson;Andriy Moshyk;Srividya Kotapati
- 期刊名称：《Experimental Hematology Oncology》 | 2019年第1期
- Advanced melanomaMelanomaNivolumabIpilimumabHealthcare cost comparisonCheckMate 067NCT01844505;
59.Ibrutinib inhibits antibody dependent cellular cytotoxicity induced by rituximab or obinutuzumab in MCL cell lines, not overcome by addition of lenalidomide

机译：Ibrutinib抑制Rituximab或Obinutuzumab在MCL细胞系中诱导的抗体依赖性细胞毒性，未加入Lenalidomide
- 作者：Alexandra Albertsson-Lindblad;Catja Freiburghaus;Mats Jerkeman;Sara Ek
- 期刊名称：《Experimental Hematology Oncology》 | 2019年第1期
- Mantle cell lymphomaAntibody-dependent cell deathIbrutinibLenalidomideCD20 antibody;
60.Frontline therapies for untreated chronic lymphoid leukemia

机译：Frontline疗法未经治疗的慢性淋巴白血病
- 作者：Delong Liu;Juanjuan Zhao
- 期刊名称：《Experimental Hematology Oncology》 | 2019年第1期
- Chronic lymphoid leukemiaVenetoclaxIbrutinibALLIANCEiLLUMINATERESONATE-2;
61.Analysis of TET2 mutations in paroxysmal nocturnal hemoglobinuria (PNH)

机译：阵发性夜间血红蛋白（PNH）中TET2突变分析
- 作者：Camille Lobry;Ashish Bains;Leah B. Zamechek;Sherif Ibrahim;Iannis Aifantis;David J. Araten
- 期刊名称：《Experimental Hematology Oncology》 | 2019年第1期
- Paroxysmal nocturnal hemoglobinuria (PNH)TET2 geneMyeloproliferative disordersAplastic anemiaSomatic mutations;
62.A novel RNA variant of human concentrative nucleoside transporter 1 (hCNT1) that is a potential cancer biomarker

机译：一种新的人浓缩核苷转运蛋白（HCNT1）的新型RNA变体，即潜在的癌症生物标志物
- 作者：Chunmei Wang;John K. Buolamwini
- 期刊名称：《Experimental Hematology Oncology》 | 2019年第1期
- Concentrative nucleoside transporter 1 (SLC28A1)Splice variantIntron retentionhCNT1 intron retention;
63.Achievements and futures of immune checkpoint inhibitors in non-small cell lung cancer

机译：非小细胞肺癌免疫检查点抑制剂的成就与期货
- 作者：Zhenbin Qiu;Zihao Chen;Chao Zhang;Wenzhao Zhong
- 期刊名称：《Experimental Hematology Oncology》 | 2019年第1期
- Checkpoint inhibitorsNSCLCNovel therapies;
64.Autoimmune rhabdomyolysis and a multiorgan display of PD-1 inhibitor induced immune related adverse events during treatment of metastatic melanoma

机译：自身免疫性横纹肌分解和PD-1抑制剂诱导的免疫相关不良事件的多功能展示在转移性黑色素瘤中
- 作者：Hoda Z. Pourhassan;David Tryon;Brett Schaeffer;Hamid Mirshahidi;John Wong
- 期刊名称：《Experimental Hematology Oncology》 | 2019年第1期
- PD-1NivolumabMelanomaImmunotherapyImmune mediated adverse eventsMyopathyRhabdomyolysis;
65.Role of some members of chemokine/cytokine network in the pathogenesis of thalassemia and sickle cell hemoglobinopathies: a mini review

机译：趋化因子/细胞因子网络中一些成员在血症和镰状细胞血红蛋白病的发病机制中的作用：迷你评论
- 作者：Zahra Mousavi;Zinat Yazdani;Alireza Moradabadi;Fatemeh Hoseinpourkasgari;Gholamhossein Hassanshahi
- 期刊名称：《Experimental Hematology Oncology》 | 2019年第1期
- HemoglobinopathySickle-cell disease (SCD)CytokineChemokine;
66.Compassionate use of ruxolitinib in acute and chronic graft versus host disease refractory both to corticosteroids and extracorporeal photopheresis

机译：在急性和慢性接枝中使用ruxolitinib与宿主疾病的使用令人难以忍受，无论是皮质类固醇和体外光拍
- 作者：Mauricio Sarmiento Maldonado;Pablo Ramírez Villanueva;Pablo Bertín Cortes-Monroy;Veronica Jara Arias;Katherine Soto Donoso;Pablo Uribe Gonzalez;Mauricio Ocqueteau Tachini;Jose Antonio Perez-Simón
- 期刊名称：《Experimental Hematology Oncology》 | 2017年第1期
- RuxolitinibGraft versus host diseaseCorticoid refractorinessExtracorporeal photopheresis;
67.Pharmacokinetics of carfilzomib in patients with advanced malignancies and varying degrees of hepatic impairment: an open-label, single-arm, phase 1 study

机译：患有晚期恶性肿瘤和不同程度的肝损伤患者的药代动力学：开放标签，单臂，第1期研究
- 作者：Jennifer Brown;Ruth Plummer;Todd M. Bauer;Stephen Anthony;John Sarantopoulos;Filip De Vos;Mike White;Marco Schupp;Ying Ou;Ulka Vaishampayan
- 期刊名称：《Experimental Hematology Oncology》 | 2017年第1期
- CarfilzomibPharmacokineticsAdvanced malignancyHepatic impairmentOncologyProteasome inhibitor;
68.Complete biochemical response after pulmonary metastasectomy in prostate adenocarcinoma

机译：前列腺腺癌肺部转移术后完全生化反应
- 作者：Jonathan Rush;Reet Pai;Rahul A. Parikh
- 期刊名称：《Experimental Hematology Oncology》 | 2017年第1期
- Prostate adenocarcinomaPulmonary metastasisMetastasectomy;
69.Incorporation of functional elements enhances the antitumor capacity of CAR T cells

机译：掺入功能元素增强了汽车T细胞的抗肿瘤能力
- 作者：Le Qin;Ruocong Zhao;Peng Li
- 期刊名称：《Experimental Hematology Oncology》 | 2017年第1期
- CAR T cellsTumor microenvironmentCytokinesImmune checkpoint moleculesHypoxiaChemotherapeutic drugsKinase inhibitors;
70.A randomized placebo-controlled phase II study of clarithromycin or placebo combined with VCD induction therapy prior to high-dose melphalan with stem cell support in patients with newly diagnosed multiple myeloma

机译：一种随机安慰剂对照II研究克拉霉素或安慰剂与高剂量甜瓜患者在新诊断的多发性骨髓瘤患者中具有干细胞载体之前的VCD诱导治疗
- 作者：Henrik Gregersen;Trung Do;Ida Bruun Kristensen;Ulf Christian Fr?lund;Niels Frost Andersen;Lene Kongsgaard Nielsen;Christen Lykkegaard Andersen;Tobias Wirenfeldt Klausen;Annette Juul Vangsted;Niels Abildgaard
- 期刊名称：《Experimental Hematology Oncology》 | 2018年第1期
- Multiple myelomaClarithromycinBortezomibAdverse drug eventInduction chemotherapyDouble blind study;
71.Clinical confirmation to demonstrate similarity for a biosimilar pegfilgrastim: a 3-way randomized equivalence study for a proposed biosimilar pegfilgrastim versus US-licensed and EU-approved reference products in breast cancer patients receiving myelosuppressive chemotherapy

机译：临床确认，证明生物仿制性PEGFILGRASTIM的相似性：用于拟议的生物仿生蛋白的3路随机性等效研究与接受骨髓抑制化疗的乳腺癌患者的美国许可和欧盟批准的参考产品
- 作者：Kalpna Desai;Priya Misra;Sanyukta Kher;Nirmesh Shah
- 期刊名称：《Experimental Hematology Oncology》 | 2018年第1期
- BiosimilarPegfilgrastimChemotherapy-induced neutropeniaSevere neutropeniaFebrile neutropeniaAbsolute neutrophil count;
72.An integrated view of the role of miR-130b/301b miRNA cluster in prostate cancer

机译：miR-130b / 301b miRNA簇在前列腺癌中的作用的综合图
- 作者：Rafael Sebastián Fort;Cecilia Mathó;Carolina Oliveira-Rizzo;Beatriz Garat;José Roberto Sotelo-Silveira;María Ana Duhagon
- 期刊名称：《Experimental Hematology Oncology》 | 2018年第1期
- hsa-miR-301bhsa-miR-130bTCGAmiRNAProstateCancerDNA MethylationTranscriptomeMicroarrayClinical outcome;
73.Potential added value of a RT-qPCR method of SOX 11 expression, in the context of a multidisciplinary diagnostic assessment of B cell malignancies

机译：SOX 11表达式的RT-QPCR方法的潜在附加值，在B细胞恶性肿瘤的多学科诊断评估的背景下
- 作者：Julien Magne;Alizée Jenvrin;Adrien Chauchet;Olivier Casasnovas;Anne Donzel;Laurence Jego;Bernard Aral;Julien Guy;Nathalie Nadal;Dewi Vernerey;Patrick Callier;Francine Garnache-Ottou;Christophe Ferrand
- 期刊名称：《Experimental Hematology Oncology》 | 2018年第1期
- Mantle cell lymphomaSOX11RT-qPCR-reference genesROC curve analysis-threshold;
74.Phase 2 study of everolimus for relapsed or refractory classical Hodgkin lymphoma

机译：everolimus对复发或难治性典型霍奇金淋巴瘤的第2阶段研究
- 作者：Patrick B. Johnston;Lauren C. Pinter-Brown;Ghulam Warsi;Kristen White;Radhakrishnan Ramchandren
- 期刊名称：《Experimental Hematology Oncology》 | 2018年第1期
- Clinical trialEverolimusHodgkin lymphomamTOR inhibitorsRelapsed/refractory;
75.Metastatic squamous cell carcinoma of the skin with clinical response to lapatinib

机译：皮肤转移鳞状细胞癌，临床反应Lapatinib
- 作者：John D. Strickley;Aaron C. Spalding;M. Tye Haeberle;Timothy Brown;Don A. Stevens;Jae Jung
- 期刊名称：《Experimental Hematology Oncology》 | 2018年第1期
- Metastatic cutaneous squamous cell carcinomaLapatinibERBB3Next generation sequencing;
76.Personalized prescription of tyrosine kinase inhibitors in unresectable metastatic cholangiocarcinoma

机译：酪氨酸激酶抑制剂中的个性化处方在不可切种的转移性胆管癌中
- 作者：Elena V. Poddubskaya;Madina P. Baranova;Daria O. Allina;Philipp Y. Smirnov;Eugene A. Albert;Alexey P. Kirilchev;Alexey A. Aleshin;Marina I. Sekacheva;Maria V. Suntsova
- 期刊名称：《Experimental Hematology Oncology》 | 2018年第1期
- Tyrosine Kinase Inhibitor (TKI)CholangiocarcinomaPazopanibSorafenib AdministrationHand-foot Syndrome;
77.Understanding metabolic changes in aging bone marrow

机译：了解老化骨髓的代谢变化
- 作者：Kwasi M. Connor;Young Hsu;Pardeep Kumar Aggarwal;Stephen Capone;Anthony R. Colombo;Giridharan Ramsingh
- 期刊名称：《Experimental Hematology Oncology》 | 2018年第1期
- Bone Marrow AgeAged MarrowNucleic Acid PoolChemotherapy ExposureChemotherapy-treated Mice;
78.Daratumumab binds to mobilized CD34+ cells of myeloma patients in vitro without cytotoxicity or impaired progenitor cell growth

机译：达拉穆曼在没有细胞毒性或祖细胞生长受损的情况下，在体外动员骨髓瘤患者的CD34 +细胞。祖细胞生长受损
- 作者：Xun Ma;Sandy W. Wong;Ping Zhou;Chakra P. Chaulagain;Parul Doshi;Andreas K. Klein;Kellie Sprague;Adin Kugelmass;Denis Toskic;Melissa Warner;Kenneth B. Miller;Lisa Lee;Cindy Varga;Raymond L. Comenzo
- 期刊名称：《Experimental Hematology Oncology》 | 2018年第1期
- MyelomaDaratumumabCD34+Progenitor cells;
79.The association of HLA-C alleles with multiple myeloma in Chinese patients

机译：HLA-C等位基因在中国患者中具有多种骨髓瘤的关系
- 作者：Xiaojing Wang;Gang An;Jiying Wang;Yan Zhang;Qinghua Li;Hui wei;Lugui Qiu;Kun Ru
- 期刊名称：《Experimental Hematology Oncology》 | 2018年第1期
- Multiple myelomaHuman leukocyte antigenAlleleChinese population;
80.Mechanisms for estrogen receptor expression in human cancer

机译：人癌中雌激素受体表达的机制
- 作者：Hui Hua;Hongying Zhang;Qingbin Kong;Yangfu Jiang
- 期刊名称：《Experimental Hematology Oncology》 | 2018年第1期
- CancerEstrogen receptorTranscriptionEpigenetic modification;
81.Development and clinical application of anti-HER2 monoclonal and bispecific antibodies for cancer treatment

机译：抗HER2单克隆和双特异性癌症治疗的开发与临床应用
- 作者：Shengnan Yu;Qian Liu;Xinwei Han;Shuang Qin;Weiheng Zhao;Anping Li;Kongming Wu
- 期刊名称：《Experimental Hematology Oncology》 | 2017年第1期
- HER2TrastuzumabPertuzumabT-DM1Bispecific antibodyErtumaxomabMM-111HER2Bi-aATCs;
82.Post-transplant lymphoproliferative disorder (PTLD): single institutional experience of 141 patients

机译：移植后淋巴移植症（PTLD）：141例患者的单一制度体验
- 作者：Rohit Bishnoi;Ravneet Bajwa;Aaron J. Franke;William Paul Skelton;Yu Wang;Niraj M. Patel;William Birdsall Slayton;Fei Zou;Nam H. Dang
- 期刊名称：《Experimental Hematology Oncology》 | 2017年第1期
- PTLDPost-transplant lymphoproliferative disorderPrognostic factors for PTLDEBV PTLDRituximab for PTLD;
83.Cost-effectiveness of nivolumab in patients with advanced renal cell carcinoma treated in the United States

机译：在美国治疗晚期肾细胞癌患者中Nivolumab的成本效益
- 作者：Charles McCrea;Sukhvinder Johal;Shuo Yang;Justin Doan
- 期刊名称：《Experimental Hematology Oncology》 | 2018年第1期
- Cost-effectivenessEverolimusNivolumabRenal cell carcinomaSurvival model;
84.Are patients with high-risk polycythemia vera receiving cytoreductive medications? A retrospective analysis of real-world data

机译：是否具有高危多胆症Vera接受细胞射入药物的患者？对现实世界数据的回顾性分析
- 作者：Dilan Paranagama;Philomena Colucci;Kristin A. Evans;Machaon Bonafede;Shreekant Parasuraman
- 期刊名称：《Experimental Hematology Oncology》 | 2018年第1期
- AnagrelideHydroxyureaInterferonsMyeloproliferative disordersPolycythemia vera;
85.Methylome of human senescent hematopoietic progenitors

机译：人衰老造血祖细胞的甲基杂物
- 作者：Stephen Capone;Anthony R. Colombo;Benjamin K. Johnson;Tim J. Triche;Giridharan Ramsingh
- 期刊名称：《Experimental Hematology Oncology》 | 2018年第1期
- SenescenceHematopoietic stem and progenitor cellsInflammationTransposable elementsEndogenous retrovirusesWhole genome bisulfite sequencingMethylationCEBPβTranscriptome;
86.Aplastic anemia secondary to nivolumab and ipilimumab in a patient with metastatic melanoma: a case report

机译：患有转移性黑色素瘤的患者中的幼虫和IPILIMIMAB中继发性的增殖性贫血：案例报告
- 作者：D. E. Meyers;W. F. Hill;A. Suo;V. Jimenez-Zepeda;T. Cheng;N. A. Nixon
- 期刊名称：《Experimental Hematology Oncology》 | 2018年第1期
- Immune checkpoint blockadeImmunotherapyPD-1CTLA-4MelanomaAdverse events;
87.Correlation of plasma concentration and adverse effects of bosutinib: standard dose or dose-escalation regimens of bosutinib treatment for patients with chronic myeloid leukemia

机译：血管素浓度和毛托替尼的血浆浓度和不良反应的相关性：培养乳酸骨髓性白血病患者的毛丁尼治疗标准剂量或剂量升级方案
- 作者：Akiko Mita;Maiko Abumiya;Masatomo Miura;Takenori Niioka;Saori Takahashi;Tomoko Yoshioka;Yoshihiro Kameoka;Naoto Takahashi
- 期刊名称：《Experimental Hematology Oncology》 | 2018年第1期
- BosutinibDiarrheaLiver dysfunctionTrough concentrationChronic myeloid leukemia;
88.Organoid technology in disease modelling, drug development, personalized treatment and regeneration medicine

机译：有机型技术在疾病建模，药物开发，个性化治疗和再生药中
- 作者：Hanxiao Xu;Ying Jiao;Shuang Qin;Weiheng Zhao;Qian Chu;Kongming Wu
- 期刊名称：《Experimental Hematology Oncology》 | 2018年第1期
- OrganoidsDevelopmentInfectious diseasesGenetic diseasesCancerDrug developmentPrecision medicineRegeneration medicine;
89.Bone marrow transplant-associated thrombotic microangiopathy without peripheral blood schistocytes: a case report and review of the literature

机译：骨髓移植相关血栓性微肺病理没有外周血血小霉素：文献报告和审查
- 作者：Eric Wirtschafter;Christine VanBeek;Yuliya Linhares
- 期刊名称：《Experimental Hematology Oncology》 | 2018年第1期
- Allogeneic hematopoietic stem cell transplant (HSCT)Transplant-associated thrombotic microangiopathy (TA-TMA)Thrombotic microangiopathy (TMA)EculizumabCase report;
90.Early vs. late MRD response- and risk-based treatment intensification of childhood acute lymphoblastic leukemia: a prospective pilot study from Saudi Arabia

机译：与早期的MRD响应和基于风险的治疗强化儿童急性淋巴细胞白血病：沙特阿拉伯的预期试验研究
- 作者：Wasil Jastaniah;Naglla Elimam;Khalid Abdalla;Aeshah A. AlAzmi;Aml M. Elgaml;Ahmad Alkassar;Mustafa Daghistani;Sami Felimban
- 期刊名称：《Experimental Hematology Oncology》 | 2018年第1期
- Acute lymphoblastic leukemiaTreatmentStratificationMRDResponseRiskChildren;
91.Deep sustained response to daratumumab monotherapy associated with T-cell expansion in triple refractory myeloma

机译：对三重难治性骨髓瘤中与T细胞扩张相关的达拉姆努单药治疗的深度持续反应
- 作者：Saad Z. Usmani;Imran Khan;Christopher Chiu;David Foureau;Lawrence J. Druhan;Katherine Rigby;Tineke Casneuf;A. Kate Sasser
- 期刊名称：《Experimental Hematology Oncology》 | 2018年第1期
- DaratumumabImmune responseMultiple myelomaStringent complete responseSustained responseT-cell expansionTriple refractoryMinimal residual disease;
92.The role of neoantigen in immune checkpoint blockade therapy

机译：Neoantigen在免疫检查点阻断治疗中的作用
- 作者：Ming Yi;Shuang Qin;Weiheng Zhao;Shengnan Yu;Qian Chu;Kongming Wu
- 期刊名称：《Experimental Hematology Oncology》 | 2018年第1期
- NeoantigenPD-1/PD-L1CTLA-4ImmunotherapyCancer vaccineAdoptive T cell transfer;
93.Conservative management of nivolumab-induced pericardial effusion: a case report and review of literature

机译：Nivolumab诱导的心包积液的保守管理 - 以案例报告和文学审查
- 作者：Shagufta Shaheen;Hamid Mirshahidi;Gayathri Nagaraj;Chung-Tsen Hsueh
- 期刊名称：《Experimental Hematology Oncology》 | 2018年第1期
- Non-small cell lung cancerImmune checkpoint inhibitorNivolumabPericardial effusionCorticosteroids;
94.Bullous hemorrhagic dermatosis is an under-recognized side effect of full dose low-molecular weight heparin: a case report and review of the literature

机译：大疱性出血性皮肤病是全剂量低分子量肝素的公认副作用：一个案例报告和对文献的审查
- 作者：Armand Russo;Susanna Curtis;Raisa Balbuena-Merle;Roxanne Wadia;Ellice Wong;Herta H. Chao
- 期刊名称：《Experimental Hematology Oncology》 | 2018年第1期
- Bullous hemorrhagic dermatosisEnoxaparinLow molecular weight heparin;
95.The epidemiology and clinical characteristics of myeloproliferative neoplasms in Malaysia

机译：马来西亚野叶瘤的流行病学与临床特征
- 作者：Yee Yee Yap;Kian Boon Law;Jameela Sathar;Ngee Siang Lau;Ai Sim Goh;Teng Keat Chew;Soo Min Lim;Padmini Menon;Yong Khee Guan;Azlan Bin Husin;Lily Lee Lee Wong;Lee Ping Chew;Sinari Salleh;Kim Yen Goh;Kin Wah Leong;Sen Mui Tan;Tee Chuan Ong;Su Hong Lim;See Guan Toh;Xavier Sim Yoon Han;Syed Carlo Edmund;Jenq Tzong Tan;Kian Meng Chang
- 期刊名称：《Experimental Hematology Oncology》 | 2018年第1期
96.Emerging therapies in advanced hepatocellular carcinoma

机译：高级肝细胞癌的新出现疗法
- 作者：Sowmini Medavaram;Yue Zhang
- 期刊名称：《Experimental Hematology Oncology》 | 2018年第1期
- Advanced HCCTKIImmunotherapyChemotherapy;
97.PAN3–PSMA2 fusion resulting from a novel t(7;13)(p14;q12) chromosome translocation in a myelodysplastic syndrome that evolved into acute myeloid leukemia

机译：Pan3-psma2融合由新型t（7; 13）（p14; q12）染色体易位在骨髓增生综合征中的染色体易位，从而进化为急性髓性白血病
- 作者：Ioannis Panagopoulos;Ludmila Gorunova;Hege Kilen Andersen;Astrid Bergrem;Anders Dahm;Kristin Andersen;Francesca Micci;Sverre Heim
- 期刊名称：《Experimental Hematology Oncology》 | 2018年第1期
- Myelodysplastic syndromeAcute myeloid leukemiaChromosome translocationt(713)(p14q12)RNA sequencingPAN3–PSMA2 fusionPAN2/PAN3 complexProteasome;
98.Early detection of transformation to BPDCN in a patient with MDS

机译：早期检测MDS患者对BPDCN的转化
- 作者：Kamal Chamoun;Sanam Loghavi;Naveen Pemmaraju;Marina Konopleva;Michael Kroll;Madeleine Nguyen-Cao;Marisa Hornbaker;Courtney D. DiNardo;Tapan Kadia;Jeffrey Jorgensen;Michael Andreeff;Shimin Hu;Christopher B. Benton
- 期刊名称：《Experimental Hematology Oncology》 | 2018年第1期
- Myelodysplastic syndromesPrognosisBPDCNMDSEarly detection;
99.Phosphatase of regenerating liver-3 (PRL-3) is overexpressed in classical Hodgkin lymphoma and promotes survival and migration

机译：再生肝-3（PRL-3）的磷酸酶在典型霍奇金淋巴瘤中过表达，促进生存和迁移
- 作者：Magnus Aassved Hjort;H?kon Hov;Pegah Abdollahi;Esten Nymoen Vandsemb;Unn-Merete Fagerli;Bendik Lund;Tobias Schmidt Sl?rdahl;Magne B?rset;Torstein Baade R?
- 期刊名称：《Experimental Hematology Oncology》 | 2018年第1期
- PRL-3Hodgkin lymphomaIL-13STAT6MigrationSurvival;
100.Temporality of heparin-induced antibodies: a retrospective study in outpatients undergoing hemodialysis on unfractionated heparin

机译：肝素诱导的抗体的临时性：在未分支肝素上进行血液透析的关门剂的回顾性研究
- 作者：Satish Maharaj;Simone Chang;Karan Seegobin;James Morales;Agnes Aysola;Fauzia Rana;Marwan Shaikh
- 期刊名称：《Experimental Hematology Oncology》 | 2018年第1期
- AntibodiesHemodialysisHeparinHITThrombocytopeniaThrombosis;

客服邮箱：kefu@zhangqiaokeyan.com

客服微信
服务号